Kamalam Unninayar
CIK 1720065 · View on SEC EDGAR ↗
First SEC filing: April 2, 2019 · Latest: April 2, 2019
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 7, 2019 | HBIO | A | 37,995 | — | — | 54,861 Direct | +225.28% | Acquired | (price as of 2026-08-21) |
| March 7, 2019 | HBIO | A | 18,997 | — | — | 73,858 Direct | +34.63% | Acquired | (price as of 2026-08-21) |
| March 7, 2019 | HBIO | A | 91,139 | — | — | 91,139 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 1, 2019 | HBIO | F | 1,603 | $3.18 | $5,098 | 16,866 Direct | -8.68% | Disposed | -76.1% (price as of 2026-08-21) |
| Nov. 26, 2018 | HBIO | A | 44,585 | — | — | 44,585 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 26, 2018 | HBIO | A | 18,469 | — | — | 18,469 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 7, 2019 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (91,139) | $3.79 | March 7, 2029 | 91,139 | Acquired |
| Nov. 26, 2018 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share (44,585) | $3.79 | Nov. 26, 2028 | 44,585 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $150,385 | — | — | — | — | — | — | $520,290 |
| 2018 | $26,154 | $10,000 | — | $69,998 | — | — | — | $176,150 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.